7% NaCl ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	2

299. 嚢胞性線維症

---

臨床試験数 : 1,696 /  薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02141191 (ClinicalTrials.gov)	June 2014	12/5/2014	A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device	A Randomized Crossover Mucociliary Clearance Study of Aerosolized 7% NaCl Solution Administered Overnight by the tPAD Device to Subjects With Cystic Fibrosis	Cystic Fibrosis	Drug: inhaled hypertonic saline (7%)	University of Pittsburgh	Parion Sciences	Completed	18 Years	N/A	All	12	Phase 1	United States
2	NCT00274391 (ClinicalTrials.gov)	July 2001	9/1/2006	Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis	Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis	Cystic Fibrosis	Drug: 7% NaCl;Drug: Amiloride HCl	University of North Carolina	Cystic Fibrosis Foundation Therapeutics	Completed	14 Years	N/A	Both	24	Phase 2	United States